Childhood Cancer Awareness Month 2026: Horizon Europe projects advancing novel treatments for rare and high-risk paediatric cancers

Imported from official source

Announcement

Safety Classified by Officially

The EU Cancer Mission, together with Europe's Beating Cancer Plan, represents the European Commission's strategy to fight cancer. Cancer in children, adolescents and young adults (CAYA) is systematically prioritised in all research topics funded by the EU Cancer Mission, with at least 20 per cent of its budget committed to date to power cutting-edge research across the entire cancer continuum for CAYA cancer.  Fortunately, cancer treatments have been improving so that most childhood cancer patients in Europe will become long-term survivors. However, rare and high-risk paediatric cancers remain challenging to treat. The recently started projects EPICA-DIPG, THEODORA and PHOENIX are advancing treatment research for rare and high-risk paediatric cancers as part of the Horizon Europe-funded Cancer Mission cluster “Diagnosis and Treatment - innovative clinical trials for paediatric cancer”. 

EPICA-DIPG will work towards a treatment for Diffuse Intrinsic Pontine Glioma (DIPG), the deadliest paediatric cancer with no existing effective therapies to date and over 300 new cases annually in Europe. The cancer is usually diagnosed at around seven years of age and progresses very quickly. Fewer than 10% of patients survive two years post-diagnosis. Surgery is impossible and chemotherapy ineffective, leaving radiotherapy as only temporary relief. Innovative treatment options are urgently needed. EPICA-DIPG will conduct the first European multinational trial using combinatorial immunotherapy in children with DIPG. A specific medical test (companion diagnostic) will enable minimally invasive, real-time monitoring of immune responses and disease burden. Thereby, the project aims to set a model for accelerated, equitable access to advanced therapies in rare childhood cancers across Europe and beyond. 

This is an extract. The publication continues at the source.

© European Union — excerpt, reused under CC BY 4.0. Licence

Read the original at the source: https://hadea.ec.europa.eu/news/childhood-cancer-awareness-month-2026-horizon-europe-projects-advancing-novel-treatments-rare-and-2026-09-25_en

Officially imported this from European Health and Digital Executive Agency’s own source and shows an extract. If you work there, claiming the profile and verifying the domain lets you choose to show the full text here.

Provenance

Organization
European Health and Digital Executive Agency — imported from official source
Official source
https://hadea.ec.europa.eu/node/2/rss_en RSS
Imported
October 03, 2026 20:30
Versions
1 recorded
Identity
https://hadea.ec.europa.eu/news/childhood-cancer-awareness-month-2026-horizon-europe-pr...

Officially records where a publication came from, not whether it is true. Imported records are reproduced from an organization's own official source.